ArticleArchives of medical science : AMS2021

Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome.

Hanna Przepiera-Będzak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.